Cervical cancer is the fourth most prevalent cancer among women on a global scale, comprising approximately 604,000 new cases and leading to 342,000 deaths worldwide. Few diseases demonstrate global disparities as distinctly as cervical cancer. Almost 90% of the fatalities in 2020 transpired in low- and middle-income nations, which face delays in vaccination, screening, and treatment. In August 2020, the Global Strategy for the elimination of cervical cancer was embraced by the World Health Assembly. To be realized by the year 2030, the WHO has instituted global objectives denoted as 90-70-90: ensuring a 90% completion rate for HPV vaccination among…